Future directions for the use of hypomethylating agents

被引:19
作者
Garcia-Manero, G
Gore, SD
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Johns Hopkins Univ, Sidney Kimmel Comprehensj Canc Ctr, Baltimore, MD USA
关键词
D O I
10.1053/j.seminhematol.2005.05.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epigenetics refers to heritable changes in DNA and chromatin that impact gene expression without a change in DNA sequence. Two major steps involved in epigenetic regulation of gene expression include methylation of the promoter region of the gene and deacetylation of specific lysine residues on promoter-associated histones leading to changes in chromatin structure. Promoter hypermethylation is the most extensively studied epigenetic process. Our expanding knowledge of this process has led to its application in the diagnosis, prognosis, and treatment of various hematologic and neoplastic diseases. Several agents, which reverse promoter methylation or inhibit histone deacetylases, are under development for use alone or in combination for a variety of neoplastic diseases. This review discusses the potential use of methylation reversing agents in the treatment of solid tumors and in benign hematologic disorders along with the rationale for combination therapies using hypomethylating agents. © 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:S50 / S59
页数:10
相关论文
共 85 条
[1]   THE EORTC EARLY CLINICAL-TRIALS COOPERATIVE GROUP EXPERIENCE WITH 5-AZA-2'-DEOXYCYTIDINE (NSC-127716) IN PATIENTS WITH COLO-RECTAL, HEAD AND NECK, RENAL CARCINOMAS AND MALIGNANT MELANOMAS [J].
ABELE, R ;
CLAVEL, M ;
DODION, P ;
BRUNTSCH, U ;
GUNDERSEN, S ;
SMYTH, J ;
RENARD, J ;
VANGLABBEKE, M ;
PINEDO, HM .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (12) :1921-1924
[2]   NUMBER OF CPG ISLANDS AND GENES IN HUMAN AND MOUSE [J].
ANTEQUERA, F ;
BIRD, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11995-11999
[3]  
ANZAI H, 1992, CANCER RES, V52, P2180
[4]   Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene [J].
Bachman, KE ;
Park, BH ;
Rhee, I ;
Rajagopalan, H ;
Herman, JG ;
Baylin, SB ;
Kinzler, KW ;
Vogelstein, B .
CANCER CELL, 2003, 3 (01) :89-95
[5]   Histone methylation: Dynamic or static? [J].
Bannister, AJ ;
Schneider, R ;
Kouzarides, T .
CELL, 2002, 109 (07) :801-806
[6]   DNA METHYLTRANSFERASES [J].
BESTOR, TH ;
VERDINE, GL .
CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (03) :380-389
[7]   Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer [J].
Cameron, EE ;
Bachman, KE ;
Myöhänen, S ;
Herman, JG ;
Baylin, SB .
NATURE GENETICS, 1999, 21 (01) :103-107
[8]   THE TUMORIGENICITY OF 5-AZACYTIDINE IN THE MALE FISCHER RAT [J].
CARR, BI ;
REILLY, JG ;
SMITH, SS ;
WINBERG, C ;
RIGGS, A .
CARCINOGENESIS, 1984, 5 (12) :1583-1590
[9]   EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].
CHARACHE, S ;
TERRIN, ML ;
MOORE, RD ;
DOVER, GJ ;
BARTON, FB ;
ECKERT, SV ;
MCMAHON, RP ;
BONDS, DR ;
ORRINGER, E ;
JONES, S ;
STRAYHORN, D ;
ROSSE, W ;
PHILLIPS, G ;
PEACE, D ;
JOHNSONTELFAIR, A ;
MILNER, P ;
KUTLAR, A ;
TRACY, A ;
BALLAS, SK ;
ALLEN, GE ;
MOSHANG, J ;
SCOTT, B ;
STEINBERG, M ;
ANDERSON, A ;
SABAHI, V ;
PEGELOW, C ;
TEMPLE, D ;
CASE, E ;
HARRELL, R ;
CHILDERIE, S ;
EMBURY, S ;
SCHMIDT, B ;
DAVIES, D ;
KOSHY, M ;
TALISCHYZAHED, N ;
DORN, L ;
PENDARVIS, G ;
MCGEE, M ;
TELFER, M ;
DAVIS, A ;
CASTRO, O ;
FINKE, H ;
PERLIN, E ;
SITEMAN, J ;
GASCON, P ;
DIPAOLO, P ;
GARGIULO, S ;
ECKMAN, J ;
BAILEY, JH ;
PLATT, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322
[10]   TREATMENT OF SICKLE-CELL-ANEMIA WITH 5-AZACYTIDINE RESULTS IN INCREASED FETAL HEMOGLOBIN PRODUCTION AND IS ASSOCIATED WITH NONRANDOM HYPOMETHYLATION OF DNA AROUND THE GAMMA-DELTA-BETA-GLOBIN GENE-COMPLEX [J].
CHARACHE, S ;
DOVER, G ;
SMITH, K ;
TALBOT, CC ;
MOYER, M ;
BOYER, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (15) :4842-4846